Treatment, clinical outcomes, and predictors of mortality among a national cohort of hospitalized patients with Stenotrophomonas maltophilia infection
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment, clinical outcomes, and predictors of mortality among a national cohort of hospitalized patients with Stenotrophomonas maltophilia infection
Authors
Keywords
-
Journal
PUBLIC HEALTH
Volume 214, Issue -, Pages 73-80
Publisher
Elsevier BV
Online
2022-12-14
DOI
10.1016/j.puhe.2022.10.025
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Analysis and Management of Long-Stay Patients
- (2021) Chienhsiu Huang International Journal of General Medicine
- Stenotrophomonas maltophilia Infections: Clinical Characteristics and Factors Associated with Mortality of Hospitalized Patients
- (2020) Worachart Insuwanno et al. Infection and Drug Resistance
- National trends in the treatment of urinary tract infections among Veterans’ Affairs Community Living Center residents
- (2019) Haley J. Appaneal et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Risk factors for mortality in patients with Stenotrophomonas maltophilia bacteremia and clinical impact of quinolone–resistant strains
- (2019) Eun Jin Kim et al. BMC INFECTIOUS DISEASES
- Levofloxacin-resistant Stenotrophomonas maltophilia: risk factors and antibiotic susceptibility patterns in hospitalized patients
- (2019) Ching Hsun Wang et al. JOURNAL OF HOSPITAL INFECTION
- Prognostic factors of health care–associated bloodstream infection in adult patients ≥40 years of age
- (2018) Hsuan-Yin Ma et al. AMERICAN JOURNAL OF INFECTION CONTROL
- Trimethoprim: The overlooked component of trimethoprim-sulfamethoxazole idiosyncratic adverse drug reactions
- (2018) Jennifer L. Goldman et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Monotherapy with minocycline or trimethoprim/sulfamethoxazole for treatment ofStenotrophomonas maltophiliainfections
- (2016) Elizabeth Hand et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Risk factors for levofloxacin resistance in Stenotrophomonas maltophilia from respiratory tract in a regional hospital
- (2015) Chien-Jung Pien et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Risk Factors Associated with Stenotrophomonas maltophilia Bacteremia: A Matched Case-Control Study
- (2015) Kosuke Sumida et al. PLoS One
- Can Levofloxacin Be a Useful Alternative to Trimethoprim-Sulfamethoxazole for Treating Stenotrophomonas maltophilia Bacteremia?
- (2013) Sun Young Cho et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
- (2012) J. S. Brooke CLINICAL MICROBIOLOGY REVIEWS
- Stenotrophomonas maltophilia bloodstream infection: Comparison between community-onset and hospital-acquired infections
- (2012) Ya-Ting Chang et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Stenotrophomonas maltophilia Infections in a General Hospital: Patient Characteristics, Antimicrobial Susceptibility, and Treatment Outcome
- (2012) George Samonis et al. PLoS One
- Risk factors for increased mortality from hospital-acquired versus community-acquired infections in febrile medical patients
- (2009) A.B. Johan Groeneveld AMERICAN JOURNAL OF INFECTION CONTROL
- Risk factors associated with mortality of infections caused by Stenotrophomonas maltophilia: a systematic review
- (2008) J.I. Garcia Paez et al. JOURNAL OF HOSPITAL INFECTION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More